BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24382996)

  • 21. Five-year outcome of patients classified in the "unsuitable" category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite® Registry trial.
    Beitsch P; Vicini F; Keisch M; Haffty B; Shaitelman S; Lyden M
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():219-25. PubMed ID: 20853036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rise and Fall of Accelerated Partial Breast Irradiation via Brachytherapy in a Single Institution.
    Jimenez RE; Hollander L; Boyd T
    Conn Med; 2016 Jan; 80(1):29-35. PubMed ID: 26882789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation.
    Shah C; Wilkinson JB; Jawad M; Wobb J; Berry S; Mitchell C; Wallace M; Vicini FA
    Clin Breast Cancer; 2012 Dec; 12(6):392-7. PubMed ID: 23063380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion.
    Mills MN; Russo NW; Nanda RH; Wilson JP; Altoos TA; Caldwell DL; Stout LL; Dube S; Blumencranz PW; Allen KG; Diaz R
    Brachytherapy; 2021; 20(2):345-352. PubMed ID: 33317964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
    Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
    Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(®) Registry Trial.
    Beitsch PD; Wilkinson JB; Vicini FA; Haffty B; Fine R; Whitworth P; Kuerer H; Zannis V; Lyden M
    Ann Surg Oncol; 2012 Oct; 19(10):3165-70. PubMed ID: 22836556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).
    Smith BD; Arthur DW; Buchholz TA; Haffty BG; Hahn CA; Hardenbergh PH; Julian TB; Marks LB; Todor DA; Vicini FA; Whelan TJ; White J; Wo JY; Harris JR
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):987-1001. PubMed ID: 19545784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation.
    Ferraro DJ; Garsa AA; DeWees TA; Margenthaler JA; Naughton M; Aft R; Gillanders WE; Eberlein T; Matesa MA; Zoberi I
    Radiat Oncol; 2012 Mar; 7():53. PubMed ID: 22458887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An examination of nationwide trends in accelerated partial breast irradiation - The replacement of breast brachytherapy with intraoperative radiotherapy and external beam radiation.
    Ladbury C; Liu J; Radany E; Vora N; Amini A; Beriwal S; Yashar C; Shah C; Glaser S
    Radiother Oncol; 2022 Jan; 166():79-87. PubMed ID: 34838893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
    Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
    Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.
    Zauls AJ; Watkins JM; Wahlquist AE; Brackett NC; Aguero EG; Baker MK; Jenrette JM; Garrett-Mayer E; Harper JL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):21-9. PubMed ID: 20951508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
    Schwartzberg BS; Chin DT; Dorn PL; Herron DS; Howell KT; Kemmis TJ; Miller SA; Moore JA; Paul D
    Am J Surg; 2018 Oct; 216(4):689-693. PubMed ID: 30041733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
    Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
    Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean Breast Cancer Patients (KROG 22-15).
    Chun SJ; Jo JH; Kim YB; Park S; Ahn SJ; Kim SS; Kim K; Shin KH
    Cancer Res Treat; 2024 Apr; 56(2):549-556. PubMed ID: 38062705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation.
    Kennedy WR; Roach MC; Thomas MA; Ochoa L; Altman MB; Hernandez-Aya LF; Cyr AE; Margenthaler JA; Zoberi I
    Pract Radiat Oncol; 2020; 10(3):e128-e135. PubMed ID: 31541717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
    Haque W; Verma V; Haque A; Butler EB; Teh BS
    Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).
    Ahmed F; Christos PJ; Singh P; Parashar B; Wernicke AG
    Am J Clin Oncol; 2019 May; 42(5):446-453. PubMed ID: 30973374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline.
    Buchholz TA; Somerfield MR; Griggs JJ; El-Eid S; Hammond ME; Lyman GH; Mason G; Newman LA
    J Clin Oncol; 2014 May; 32(14):1502-6. PubMed ID: 24711553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.